Immune Design Corp.
Patents, Design & Utilities

Last updated:

List of all Immune Design Corp. patents 15 in total

Status Patent
Grant
Utility: Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 21 Jun 2022
Application
Utility: RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS External link
Filling date: 6 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS External link
Filling date: 6 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER External link
Filling date: 6 Sep 2025 Issue date: 24 Feb 2022
Grant
Utility: Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids External link
Filling date: 6 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Materials and methods for producing improved lentiviral vector particles External link
Filling date: 6 Sep 2025 Issue date: 4 May 2021
Grant
Utility: GLA monotherapy for use in cancer treatment External link
Filling date: 6 Sep 2025 Issue date: 4 May 2021
Application
Utility: A RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Grant
Utility: Multigenome retroviral vector preparations and methods and systems for producing and using same External link
Filling date: 6 Sep 2025 Issue date: 10 Mar 2020
Application
Utility: MATERIALS AND METHODS FOR PRODUCING IMPROVED LENTIVIRAL VECTOR PARTICLES External link
Filling date: 6 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: VACCINES FOR HSV-2 External link
Filling date: 6 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: COMPOSITIONS COMPRISING LENTIVIRAL VECTORS EXPRESSING IL-12 AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 12 Dec 2019
Application
Utility: GLA Monotherapy for use in Cancer Treatment External link
Filling date: 6 Sep 2025 Issue date: 5 Sep 2019
Grant
Utility: Materials and methods for producing improved lentiviral vector particles External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2019
Grant
Utility: Vaccines for HSV-2 External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2019

Showing 1 to 15 of 15 patents.